Litek Pharma at Faro: Innovation in Childhood Cancer Research
The Importance of Research in Pediatric Oncology
Childhood cancer remains a significant medical challenge that requires continuous research and innovation. While advances in oncology have improved survival rates, the development of advanced therapies remains crucial to ensuring more effective and less aggressive treatments for children.
Events like the one organized by FARO, as part of International Childhood Cancer Day, play a vital role in raising awareness and driving biomedical research. Bringing together healthcare experts, associations, and families creates a platform for dialogue where current challenges and scientific breakthroughs shaping pediatric cancer treatment are discussed.
The FARO Event and Proyectos Infinitos: A Boost for Childhood Cancer Research
FARO and Proyectos Infinitos: A Commitment to the Fight Against Childhood Cancer
On February 11, in honor of International Childhood Cancer Day, FARO, the La Rioja Association of Relatives and Friends of Children with Cancer, organized an event that brought together healthcare experts, associations, and families. One of the event’s highlights was the presentation of Proyectos Infinitos, a solidarity initiative aimed at raising awareness about the fight against childhood cancer through stories of resilience and social awareness.
As part of the event, a video was shown about the FARO and Proyectos Infinitos gathering on June 15, 2024, where families from the association participated in outdoor activities such as a speleology tour at Cueva Peña Miel and a kayaking session at Club Náutico El Rasillo. Beyond being a recreational experience, this initiative aimed to spotlight FARO’s mission and the impact of childhood cancer on many families’ lives.
Roundtable Discussion: Advances in Pediatric Oncology Research and Therapies
One of the key moments of the event was the roundtable discussion on innovation in pediatric oncology, where industry experts analyzed the latest advancements in advanced therapies for childhood cancer.
As part of our participation in FARO, our General Director, Javier Alonso, took part in this discussion, sharing Litek Pharma’s vision on the role of technology in research and the development of more effective oncological treatments.
This session featured prominent biomedical professionals, including:
Andrea Romero (Konexio Biotech)
Felisa Vázquez (Brain Tumor Unit, Hospital Niño Jesús, Madrid)
Julio Vázquez (Pediatrics Specialist, Hospital San Pedro)
Moderator: Ángel Íñiguez (Farmaskills)
The discussion emphasized the importance of collaboration between the pharmaceutical industry, the medical community, and biomedical research to develop more effective and accessible treatments.
The Role of Technology in Pediatric Oncology Innovation
Advancements in cellular therapies, precision medicine, and bioengineering are revolutionizing childhood cancer treatment. Companies specializing in biomedical technology are developing equipment that enhances these treatments, helping to personalize patient care and improve therapeutic efficacy.
The FARO event was an opportunity to reaffirm the importance of technology in improving pediatric oncology treatments and the need to continue strengthening research in this field.
Litek Pharma’s Commitment to Biomedical Research
At Litek Pharma, we want to express our gratitude to FARO for inviting us to participate in such a meaningful event. Gatherings like this not only promote knowledge-sharing but also provide a real connection with those who face the battle against childhood cancer every day.
We firmly believe in the role of biomedical research and technological innovation in fighting this disease. That is why we remain committed to developing solutions that facilitate access to advanced treatments and contribute to the well-being of pediatric patients.
Collaboration between the scientific community, the industry, and patient associations is essential to driving progress. Events like FARO remind us that every effort counts and that, together, we can continue advancing research to offer a future with better opportunities for children with cancer.
